Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Reddit's search use jumps 30% YoY, boosting user growth and revenue in Q1 2026

Company Fundamentals
01 May 2026
TechCrunch
View Source
Bullish
pluang ai news

Reddit has seen a 30% year-on-year increase in weekly search users, driven by investments in AI-enhanced search features. CEO Steve Huffman highlighted search as a key factor in user acquisition and retention, with the platform reaching over 493 million weekly active users and 126 million daily active users in Q1 2026. Revenue for the quarter was $663 million, surpassing Wall Street expectations. Reddit also expanded its machine translation feature, supporting over 30 languages, contributing to user growth. The company aims to reach 1 billion daily users globally and 100 million in the U.S.

More News

Class action filed against Nano-X for alleged securities fraud, investors urged to join by Aug 11, 2026.

Class action filed against Nano-X for alleged securities fraud, investors urged to join by Aug 11, 2026.

A class action lawsuit has been filed against Nano-X Imaging Ltd. and some of its officers, accusing them of making false and misleading statements about the company's operations and prospects between March 31, 2025, and April 17, 2026. The lawsuit c...

Market News
Bearish
1 hour ago
Osteoarthritis market to grow 3% CAGR through 2036, fueled by new therapies and rising disease cases

Osteoarthritis market to grow 3% CAGR through 2036, fueled by new therapies and rising disease cases

The osteoarthritis market is projected to grow at a moderate CAGR of 3% from 2026 to 2036, driven by an aging population and increasing disease prevalence. Emerging therapies like LEVI-04, ZILOSUL, TissueGene-C, and others are expected to enter the m...

Market News
Bullish
1 hour ago
Rhythm Pharma shares rise after positive 6-month data on obesity drug setmelanotide in Prader-Willi syndrome patients.

Rhythm Pharma shares rise after positive 6-month data on obesity drug setmelanotide in Prader-Willi syndrome patients.

Rhythm Pharmaceuticals reported encouraging six-month Phase 2 trial results for setmelanotide in patients with Prader-Willi syndrome, showing improvements in BMI, body composition, hyperphagia, and behavior. The study involved 18 patients aged 6 to 2...

Company Fundamentals
Bullish
1 hour ago
FDA approves AstraZeneca's Truqap for targeted prostate cancer treatment; Ultomiris gets Priority Review for kidney disease.

FDA approves AstraZeneca's Truqap for targeted prostate cancer treatment; Ultomiris gets Priority Review for kidney disease.

AstraZeneca received FDA approval for Truqap (capivasertib) combined with abiraterone and prednisone to treat PTEN-deficient metastatic prostate cancer, marking the first targeted therapy for this group. The approval was based on Phase III trial data...

Market News
Bullish
1 hour ago
TripAdvisor sells TheFork to American Express for $700M, boosting capital return plans.

TripAdvisor sells TheFork to American Express for $700M, boosting capital return plans.

TripAdvisor has agreed to sell its European restaurant reservation platform, TheFork, to American Express for $700 million in cash. TheFork generated $232 million in revenue and $28 million in adjusted EBITDA in the past year. This sale supports Trip...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App